We aimed to assess the trends in the prevalence, awareness, treatment and control of hypertension in Finnish men and women aged 60-74 years. Three independent cross-sectional population surveys were conducted in 1997, 2002 and 2007 remained stable. The mean diastolic blood pressure (BP) decreased in both genders. Awareness of hypertension increased from 60 to 71% in men (Po0.001 for trend) and from 66 to 76% (P ¼ 0.012) in women. The prevalence of antihypertensive drug treatment among hypertensive people increased from 35 to 56% in both genders (Po0.001). The proportion of treated hypertensive patients with adequately controlled BP increased from 16 to 32% in men (Po0.001) and from 16 to 30% in women (P ¼ 0.003). Hypertension care in older adults has improved in Finland during 1997 to 2007. The situation is not optimal: the main problem in this age group is high SBP.
Introduction
Hypertension, currently defined as systolic blood pressure (SBP) X140 mm Hg or diastolic blood pressure (DBP) X90 mm Hg on the basis of repeated blood pressure (BP) recordings or treatment with antihypertensive drugs, is one of the most powerful risk factors for cardiovascular diseases (CVD). [1] [2] [3] In western countries, the prevalence of hypertension increases with increasing age. 2, 4 In older patients, mainly with systolic/diastolic hypertension, antihypertensive drug treatment has been found to decrease CVD mortality 5 and in the past, more emphasis has been placed on the lowering of DBP than SBP as a CVD risk factor. 6 During the last two decades, evidence with regard to the prevention of isolated systolic hypertension (ISH)-associated CVD in the people aged 60 years or more has markedly increased. 7 SBP has been found to be a more powerful predictor than DBP of mortality and cardiovascular complications in older persons. 2, [8] [9] [10] However, it was not until the Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood pressure (JNC V) in 1993 that SBP and ISH were specially highlighted as an important target for antihypertensive drug treatment to control high BP in the elderly for the first time. 11 In 1994, the recommendation on antihypertensive drug treatment of sustained ISH (DBPo90 mm Hg and SBPX180 mm Hg, or SBPX160 mm Hg in the presence of target organ damage) among people aged 60 years or more was included in the Finnish national guidelines. 12 During the study period of this paper, the threshold recommended internationally for the diagnosis of hypertension, the threshold for the initiation of antihypertensive drug treatment and the goal of treatment have changed in line with the increasing evidence behind the guidelines. 1, 2, 11, 13 The most recent European hypertension management guidelines have based treatment decisions mainly on the absolute CVD risk of the patient. 1, 13 If tolerated, the recommended target of BP values are the same for all patients regardless of age. 1, 2, 13 The increasing size of the elderly population together with the high prevalence of hypertension and elevated SBP predominantly among older people with a high absolute risk of CVD mortality 1, 2, 8 emphasizes the burden of the public health issue. We have now a unique opportunity to report the most recent data on the prevalence and care of hypertension, and in particular their secular trends for the first time in the older Finnish adults aged 60-74 years during 1997-2007.
Methods
Three independent cross-sectional population-based surveys were carried out in 1997, 2002 and 2007 in Finland among men and women aged 25-74 years (called the National FINRISK study) to monitor levels and trends in CVD risk factors. Random samples of people aged 25-64 years were drawn from the national population register, stratified such that 250 persons in 1997 and in 2002 and 200 persons in 2007 were chosen for each sex and 10-year age group in each study area. Since 1997, surveys also included people up to 74 years in selected geographical areas. For the purpose of this analysis, the subsets of people aged 60-74 years in the province of North Karelia and Helsinki-Vantaa region were included in the analyses, as in these areas this older age group was included in each surveys during 1997-2007. In both areas, 500 men and 250 women were selected in 1997, 250 men and women in 2002 and 200 men and women in 2007, in the age group of 65-74 years.
In 1997, the survey followed a highly standardized protocol based on the World Health Organisation Multinational Monitoring of trends and determinants in cardiovascular disease (WHO MONICA) Project protocol 14 and, since 2002, the more recent recommendation by the European Health Risk Monitoring Project; 15 these two protocols are identical regarding BP measurements. The surveys were conducted according to the ethical rules of the National Public Health Institute of Finland, after obtaining informed consent from the participants and ethical approvals, and in accordance with the declaration of Helsinki.
Nurses specially trained in survey methodology, measured BP, height, weight and waist circumference in each survey. BP was measured twice from the right arm of the person, who was seated for 5 min before the measurement. A standard mercury sphygmomanometer with a cuff bladder 14 cm wide and 40 cm long was used. The fifth phase of the Korotkoff sound was used as the DBP, and the values were recorded to the nearest 2 mm Hg. The mean of the first two measurements was used in the present analyses.
The person was considered as hypertensive if the average SBP was at least 140 mm Hg or the average DBP was at least 90 mm Hg or if he/she reported having taken antihypertensive drugs during the preceding 7 days. Information on awareness of hypertension and the use of antihypertensive drugs was obtained with a self-administered questionnaire. Awareness of hypertension was defined as a participant having reported a previous diagnosis of hypertension or current use of antihypertensive drug treatment. People on antihypertensive drug treatment, whose measured BP level was less than 140/90 mm Hg, irrespective of comorbidities such as diabetes or renal failure were considered to be adequately treated (controlled). As international guidelines for hypertension treatment recommend lower BP goals for diabetic patients, 2, 13 we performed additional analyses using a goal BP of less than 140/90 mm Hg for nondiabetic persons and less than 130/80 mm Hg in the 85 men and 78 women with self-reported diabetes or who used hypoglycaemic drug treatment at presentation.
Untreated ISH was defined as an SBP of at least 140 mm Hg and DBP less than 90 mm Hg and untreated diastolic hypertension (DHT) as DBP of at least 90 mm Hg in people without any antihypertensive drug treatment.
Excluded from the analyses were 80 men and 62 women without information on awareness of hypertension. The total number of people aged 60-74 years participating in this study was 3424 ( 1 These risk categories, termed 'low', 'moderate', 'high' and 'very high' added risk are calibrated to indicate an approximate absolute 10-year risk of fatal CVD less than 4, 4-5, 5-8 and over 8%. The cardiovascular risk factors available in the FINRISK data were age, smoking, dyslipidaemia, family history of stroke, angina pectoris, myocardial infarction, coronary revascularization and heart failure, diabetes (self-reported), pulse pressure (equal or higher than 55 mm Hg) and increased waist circumference. Waist circumference was measured from midway between the lowest rib and the iliac crest. The participants were classified as current smokers if they reported having smoked regularly for at least 1 year and during the preceding month.
Venous blood samples were drawn from each participant after at least 4 h of fasting. In the 2007 survey, the samples were centrifuged and frozen in the field survey sites, and frozen samples were transferred to the laboratory of the National Public Health Institute. Serum total cholesterol concentration was determined using enzymatic CHOD-PAP method, high-density lipoprotein-cholesterol concentration using direct enzymatic method and triglyceride concentration using enzymatic GPO method. The low-density lipoprotein cholesterol concentration was calculated using Friedewald's formula. 16 
Statistical analyses
The analyses were performed separately for men and women using SAS 9.1 for Windows statistical programs (SAS Institute Inc., Cary, NC, USA). The proportions and the means of SBP and DBP were calculated from pooled data of the 1997, 2002 and 2007 surveys for all participants combined, for participants with and without antihypertensive drug treatment and separately within 5-year age groups of 60-64, 65-69 and 70-74 years. The mean values of SBP and DBP in all men and women were adjusted for age, and differences between surveys were calculated using analysis of covariance. Trends were analysed for prevalence of hypertension, awareness and treatment of hypertension among all hypertensive patients and control of hypertension among treated hypertensive patients. In addition, we determined the prevalence of untreated ISH and DHT as well as the control rates for SBP and DBP in all men and women. In 5-year age groups, the secular trends for proportions were calculated using w 2 -test for trend of proportions. In all men and women, these estimates for prevalence, awareness, treatment and control of hypertension as well as the control rates for SBP and DBP were agestandardized. The secular trends and standard errors for these proportions were tested using the survey years as an ordinal variable in general log-linear model that included age groups and standardized using the European Standard population as a reference population. The interaction term between hypertension prevalence and geographical area was statistically significant. Therefore, we additionally assessed the statistical significance for trends adjusting for age and geographical area using w 2 -test for trend.
Results
In In 2007, the age-adjusted prevalence of hypertension was 79% for men and 78% for women. The increase in the secular trends in the prevalence of hypertension was neither significant in all men and women nor in the any of age groups (Table 3) . Adjustments for age and geographical area did not change these results. During the 10-year study period, there was a statistically significant increase in the proportion of hypertensive people who were aware on their hypertension, from 60 to 71% (Po0.001 for trend) in all men and from 66 to 76% (P ¼ 0.012 for trend) in all women. This increasing trend was significant in men aged 65-69 years and in women aged 70-74 years. The proportion of patients on antihypertensive drug treatment increased significantly in both genders as well as in all age subgroups, being 56% for both all men and all women in 2007. The control of hypertension, that is, the proportion of adequately treated hypertensive patients, improved significantly from 16% in 1997 in both all men and women to 32% in men (Po0.001 for trend) and to 30% in women (P ¼ 0.003 for trend) in 2007. The increasing trend was significant in men and women aged 65-69 years and in the women aged 60-64 years. In sensitivity analyses, using the goal of BP for diabetic patients of less than 130/80 mm Hg, the control of hypertension was 15% in 1997, 26% in 2002 and 29% in 2007 for men (Po0.001), and 13, 20 and 29% for women (P ¼ 0.005), respectively. The age-adjusted control rates of DBP less than 90 mm Hg increased from 50% in 1997 to 77% in 2007 (Po0.001 for trend) in men and from 70 to 89% (Po0.001 for trend) in women ( Table 4 ). The control of SBP less than 140 mm Hg also improved during the study period in both men (from 26 to 35%, Po0.061 for trend) and women (from 17 to 31%, Po0.001 for trend). On the basis of ESH-ESC 2007 Guidelines risk categorization, the proportions of participants in very high, high, moderate and low or average added CVD risk were 18.4, 61.7, 11.8 and 8.1%, respectively. Of the subjects with untreated hypertension (n ¼ 260), none were categorized within the lowrisk group and only 4.2% were categorized to the moderate risk group.
Discussion
The high prevalence of hypertension in older Finnish adults is in keeping with previous international comparisons in middle-aged people. 17 In particular, the lack of improvement in SBP may prevent the patients to receive the benefits of otherwise improved hypertension care. Compared with the prevalences of hypertension in our study, those reported since 2000 in other studies by age and sex have been lower in most, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] but not in all populations. 27, 28 As in our paper, the rate of awareness of hypertension in these reports was usually more than 60%. In contrast, the proportion of hypertensive patients using antihypertensive drug treatment and that of those with adequately controlled hypertension was higher than those in our study. Exceptions to this rule include a low awareness and control rates among men and women in China 21 and men in Portugal.
25 Data on trends of hypertension care for international comparison published after JNC V 11 in the older adults are scarce. An increasing trend in the prevalence of hypertension was observed in mainland China, in an urban population in Chile 23 in both men and women, and in Taiwan in men. 20 In Taiwan, from the mid-1990s to 2002 and in Chile from 1998 to 2004, the proportions of treatment and control of hypertension have increased, and in their last surveys, these were higher than the proportions in the present paper. These improvements have been attributed to the successful changes regarding the national health-care policy in these countries. 20, 23 The hypertension care showed an improvement during 2003-2006 also in the Health Survey for England in 2006, particularly in women. 26 In the National Health and Nutrition Examination Survey during 1988-2004, hypertension prevalence increased significantly in all US older adults aged 60 years or over, 19 by race/ethnicity in both non-Hispanic white and black people. 27 In older men hypertension awareness, treatment and control increased significantly and the rates reached those seen in women. Compared with the US treatment patterns, the healthcare system in Finland seems to have provided hypertension care equally in older men and women, but this is not satisfactory. Better hypertension control patterns in the United States may result from lower treatment thresholds and more intensive treatment based on more stringent guidelines for hypertension treatment and thus more active therapeutic strategies in the United States compared with Finland, although possible differences in lifestyle factors cannot be excluded. 4, 29 Systematic comparison of BP levels and hypertension-related prevalences between studies is often difficult because of the differences in study populations included in national surveys and lack of standardized methods. Our recent report from the National FINRISK Study in people aged 25-64 years suggested that despite a clear progress, hypertension care in Finland was not optimal in 2007. 30 The application of standardized methods in the National FINRISK Study provides an opportunity to assess trends in hypertension in a manner that allows systematic comparison between middle-aged persons in our papers by Kastarinen et al. 30, 31 and older adults in this paper without a concomitant measurement bias. As expected, the average SBP and the prevalence of hypertension were higher among older adults of the present study than in middle-aged persons. In 2007, the awareness of hypertension was very similar in the older and middle-aged women, but it was better in older than in middle-aged men, probably indicating more frequent visits to healthcare facilities among the older men. On the other hand, the estimated cardiovascular risk based on the European guidelines for hypertension leads to categorization where elderly people are likely to reach treatment thresholds. 13 Indeed, the proportions of hypertensive patients on antihypertensive drug treatment were higher in the older adults, but the proportions of treated patients with adequately controlled hypertension tended to be higher in middle-aged patients.
The percentages with adequately controlled hypertension as detailed in Table 3 decreased when the lower recommended goal of 130/80 mm Hg was used for diabetic patients. 2, 13 Irrespective of which cutoffs were used, the percentage of controlled hypertensive patients doubled during the 10-year period, although Prevalence, prevalence of hypertension (systolic blood pressure (SBP) X140 mm Hg or diastolic blood pressure (DBP) X90 mm Hg or antihypertensive drug treatment); awareness, awareness of the condition among hypertensive subjects; treatment, hypertensive subjects using antihypertensive drug treatment; control, treated subjects with SBPo140 mm Hg and DBPo90 mm Hg; P-value, statistical significance for trend.
a Adjusted for age. Adjusted for age; P-value, the statistical significance for trend. Adequately controlled DBPo90 mmHg and adequately controlled SBPo140 mm Hg.
this still has the effect that only a quarter of them were well controlled. It is worth noting that according to the Finnish national hypertension guidelines, the goal BP for subjects with uncomplicated diabetes since 1994 was a DBP less than 80 mm Hg 12 and since 2002 less than 140/80 mm Hg.
Among various physician-related factors, conservative treatment policy in prescribing antihypertensive drugs, even when the treatment recommendations have been identified, relates very commonly to poor BP control. 29, [32] [33] [34] Also, patient-related factors such as low compliance are partly responsible impeding achievement of goal BP. 32, 33 SBP is more difficult to treat than is DBP and larger doses and numbers of antihypertensive drugs are often required to achieve SBP control. 32, 34 DBP was far more often treated adequately than SBP in our study, as also observed in other studies. 32, 34 Although during the period from 2002 to 2007, improvement was seen also in the treatment of ISH, untreated ISH remained more frequent than untreated DHT. This finding suggests that despite recommendations included in the recent guidelines stressing the importance of the treatment of SBP in the elderly, 2, 11, 13 clinicians may still focus on DBP. On the other hand, current evidence of pharmacological treatment in patients with mild systolic hypertension is missing. Clinicians may be cautious in initiating antihypertensive drug treatment for elderly patients with Grade 1 systolic hypertension (SBP 140 mm-159 mm Hg), although in 2007, 92% of participants in our study were at least at moderate added cardiovascular risk and 80% at high added risk of CVD as defined by the guidelines in 2003. 13 In patients with ISH, lowering of elevated SBP will inevitably lead to a lowering in DBP. 7 To reach the recommended SBP goal is complicated by the fact that the optimum target level of DBP in the older treated hypertensive patient is not clear. Low DBP in elderly hypertensive patients with the use of antihypertensive drug treatment has been found to be associated with a worse cardiovascular prognosis, suggesting the existence of J-curve. [35] [36] [37] These findings have largely been suggested to result from pre-existing diseases. 35, 36, 38 On the other hand, in a meta-analysis by Wang et al., 39 lowering of DBP to levels averaging o70 mm Hg did not cause harm as long as it was associated with a lowering in SBP. Although the association between excess risk in patients with coronary heart disease and an ontreatment DBP less than 70 mm Hg does not establish a causal relationship, a caution has been suggested with excess lowering of DBP to less than 70 mm Hg in elderly patients with coronary heart disease. 40 There are still issues and clinical uncertainties, which must be considered when treatment decisions are made in older people with comorbidities. An increasing age itself has been associated with poor BP control. 41 In more than half of the population older than 65 years, multiple chronic diseases, related or unrelated to hypertension, are present. [42] [43] [44] Clinical practical guidelines for hypertension do not address older individuals with multiple comorbidities. 41 The presence of conditions unrelated to hypertension have been associated with decreased use of antihypertensive drugs in older patients, 44 although in those with hypertension-related chronic comorbidities, such as coronary heart disease and diabetes, the treatment patterns are the opposite. 33, 43 However, even though a greater proportion of older people were on multiple antihypertensive drugs, the control of hypertension was worse. 33, 41 Thus, elderly patients may have limits that may prevent them reaching the target recommended by the recent guidelines even if the patient compliance and the expertise of physician are adequate. The poor control may also be due also to inadequate selection of drug classes. Agents that lower SBP by reducing vascular stiffness might have a preferred role in the management of ISH in elderly patients with coronary heart disease. 40 In this study, hypertensive patients with adequately controlled BP by nonpharmacological therapies would have been defined as having normal BP, which may underestimate the prevalence of hypertension. On the other hand, the definition of hypertension in this study as many other epidemiological study, based on only two BP measurements on a single visit, may overestimate the prevalence of hypertension in a population. We also have performed an analysis using the second BP measurement only to reduce the possible 'white-coat' effect but it did not materially affect the results (data not shown). Older people who had serious dementia or who suffered from other serious functional inabilities were most likely unable to attend to the centres where physical examinations took place. In addition, patients with a cognitive impairment may have more problems with answering the questions in the questionnaires, which may result to the misclassification of some of results. Data for two regions in Finland were available for this study. No marked differences in the BP levels and care of hypertension have been seen between different parts of Finland in the middle-aged population. 31 Therefore, there is no reason to presume that the results presented in this paper were not representative for Finland in general. Participation rate were reasonable between 63 and 86%. It is possible that the varying of participation rates will have introduced biases, which cannot be estimated. It is unlikely that such biases would have influenced the differing trends found in SBP and DBP control.
In perspective
Despite the recent guidelines, the gap between the control of DBP and SBP favouring the DBP control has remained. SBP is more difficult to treat but some of clinicians may still focus more on high DBP rather than high SBP. In the future, we need more information based on observational population surveys of hypertension treatment and the possible improving control of hypertension across the age spectrum, including the very elderly. We plan to estimate the trends in lifestyle factors associated with trends in BP levels, especially focusing on the differences between systolic and DHT care in this FINRISK data. Future clinical trials should include older patients with representative comorbidities and find out the optimal treatment target among these people with highest prevalence of hypertension.
What is know about this topic K The high prevalence of hypertension and elevated SBP predominantly among older people with a high absolute risk of CVD mortality emphasizes the burden of the public health issue. K The benefits of antihypertensive drug treatment extend up to the very elderly. K The European guidelines have based the hypertension treatment decisions on the absolute cardiovascular risk of the patient. The recommended target of blood pressure values are the same for all patients regardless of age.
What this study adds K The age-adjusted prevalence of hypertension in these older Finnish adults remained very high in 2007. K Despite a significant increase in the proportion of hypertensive patients who were aware of their condition and the increase in the proportion of those who were on antihypertensive drug treatment during 1997-2007, less than one-third of treated patients still had their BP adequately controlled in 2007. K The lack of decrease in SBP may prohibit patients to receive full benefits of otherwise improved hypertension care.
